(NYSE: COO) Cooper Companies's forecast annual revenue growth rate of 6.52% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 6.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.21%.
Cooper Companies's revenue in 2023 is $3,308,400,000.On average, 7 Wall Street analysts forecast COO's revenue for 2023 to be $174,114,221,987, with the lowest COO revenue forecast at $168,433,779,161, and the highest COO revenue forecast at $181,694,216,345. On average, 4 Wall Street analysts forecast COO's revenue for 2024 to be $185,953,746,456, with the lowest COO revenue forecast at $178,692,087,875, and the highest COO revenue forecast at $193,415,389,001.
In 2025, COO is forecast to generate $197,007,894,613 in revenue, with the lowest revenue forecast at $197,007,894,613 and the highest revenue forecast at $197,007,894,613.